Garrett Wealth Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Sell
1,502
-11
-0.7% -$11.2K 0.28% 36
2026
Q1
$1.39M Buy
1,513
+571
+61% +$579K 0.25% 37
2025
Q4
$1.01M Hold
942
– – 0.19% 37
2025
Q3
$719K Hold
942
– – 0.14% 52
2025
Q2
$734K Sell
942
-5
-0.5% -$3.88K 0.16% 43
2025
Q1
$782K Buy
947
+5
+0.5% +$4.16K 0.17% 41
2024
Q4
$727K Buy
942
+48
+5% +$39.7K 0.17% 39
2024
Q3
$792K Hold
894
– – 0.2% 37
2024
Q2
$809K Hold
894
– – 0.3% 32
2024
Q1
$695K Hold
894
– – 0.28% 26
2023
Q4
$521K Buy
+894
New +$522K 0.22% 28
2019
Q4
– Sell
-261
Closed -$29.2K – 385
2019
Q3
$29.2K Buy
+261
New +$29.1K 0.02% 172

Other funds holding LLY

Garrett Wealth Advisory Group's LLY Position: Q2 2026 in Review

Garrett Wealth Advisory Group reduced its Eli Lilly (LLY) stake by 0.73% in Q2 2026, selling an estimated $11.2K and leaving 1,502 shares worth $1.8M. The position accounts for 0.28% of the portfolio, ranked #36.

Garrett Wealth Advisory Group first reported a position in LLY in Q3 2019 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Garrett Wealth Advisory Group held 1,502 shares of Eli Lilly worth $1.8M as of Q2 2026.
  • Garrett Wealth Advisory Group sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.28% of Garrett Wealth Advisory Group's portfolio in Q2 2026, its #36 holding.
  • Garrett Wealth Advisory Group first reported a position in Eli Lilly in Q3 2019 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Garrett Wealth Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.